334 related articles for article (PubMed ID: 27232881)
1. Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
Lei L; Yu X; Chen B; Chen Z; Wang X
PLoS One; 2016; 11(5):e0155132. PubMed ID: 27232881
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and risk factors for recurrence in mucinous breast cancer].
Lei L; Chen ZZ; Zheng YB; Chen B; Wang X; Wang XJ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):274-279. PubMed ID: 28550667
[No Abstract] [Full Text] [Related]
3. Do clinical and immunohistochemical findings of pure mucinous breast carcinoma differ from mixed mucinous breast carcinoma?
Erhan Y; Ciris M; Zekioglu O; Erhan Y; Kapkac M; Makay O; Ozdemir N
Acta Chir Belg; 2009; 109(2):204-8. PubMed ID: 19499682
[TBL] [Abstract][Full Text] [Related]
4. Micropapillary pattern in pure mucinous carcinoma of the breast - does it matter or not?
Xu X; Bi R; Shui R; Yu B; Cheng Y; Tu X; Yang W
Histopathology; 2019 Jan; 74(2):248-255. PubMed ID: 30066338
[TBL] [Abstract][Full Text] [Related]
5. Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.
Hashmi AA; Zia S; Yaqeen SR; Ahmed O; Asghar IA; Islam S; Afzal A; Irfan M; Zia F; Ali J
Cureus; 2021 Mar; 13(3):e13650. PubMed ID: 33824803
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Study of Mucinous Carcinoma of Breast with Emphasis on Cytological Features: A Study at Tertiary Care Teaching Hospital of South India.
Chikkannaiah P; Thangngeo D; Guruprasad C; Venkataramanappa S
J Lab Physicians; 2020 Mar; 12(1):68-75. PubMed ID: 32792796
[No Abstract] [Full Text] [Related]
7. Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the Breast.
Sugawara-Komatsu K; Fujii T; Kurozumi S; Ishikawa H; Katayama A; Handa T; Tougou M; Sano T; Matsumoto H; Kurosumi M; Horiguchi J; Shirabe K; Oyama T
Anticancer Res; 2024 Jun; 44(6):2689-2698. PubMed ID: 38821605
[TBL] [Abstract][Full Text] [Related]
8. Mucinous carcinoma of the breast: a multifaceted study with special reference to histogenesis and neuroendocrine differentiation.
Kato N; Endo Y; Tamura G; Katayama Y; Motoyama T
Pathol Int; 1999 Nov; 49(11):947-55. PubMed ID: 10594840
[TBL] [Abstract][Full Text] [Related]
9. Mucinous Carcinoma of the Breast: Clinicopathological Features and Long-term Prognosis in Comparison with Invasive Ductal Cancer; A Single Hospital's 30+-Year Experience.
Isozaki H; Yamamoto Y; Sakai K; Sho T; Ishihara K; Murakami S; Matsumoto S; Takama T
Acta Med Okayama; 2020 Apr; 74(2):137-143. PubMed ID: 32341588
[TBL] [Abstract][Full Text] [Related]
10. Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis.
Liu F; Yang M; Li Z; Guo X; Lin Y; Lang R; Shen B; Pringle G; Zhang X; Fu L
Breast Cancer Res Treat; 2015 Jun; 151(2):443-51. PubMed ID: 25953688
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast.
Jang Y; Jung H; Kim HN; Seo Y; Alsharif E; Nam SJ; Kim SW; Lee JE; Park YH; Cho EY; Cho SY
J Pathol Transl Med; 2020 Jan; 54(1):95-102. PubMed ID: 31718120
[TBL] [Abstract][Full Text] [Related]
13. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
14. Negative estrogen-receptor invasive breast carcinoma: mammographic aspects, correlations with HER2/neu oncoprotein status.
Enache DE; Georgescu CV; Pătrană N
Rom J Morphol Embryol; 2012; 53(3 Suppl):755-62. PubMed ID: 23188436
[TBL] [Abstract][Full Text] [Related]
15. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.
Ohashi R; Hayama A; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
Diagn Pathol; 2016 Nov; 11(1):131. PubMed ID: 27846863
[TBL] [Abstract][Full Text] [Related]
17. BI-RADS 3-5 microcalcifications: prediction of lymph node metastasis of breast cancer.
Cen D; Xu L; Zhang S; Zhou S; Huang Y; Chen Z; Li N; Wang Y; Wang Q
Oncotarget; 2017 May; 8(18):30190-30198. PubMed ID: 28415815
[TBL] [Abstract][Full Text] [Related]
18. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
[TBL] [Abstract][Full Text] [Related]
19. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]